- Conditions
- Influenza A Virus, H5N1 Subtype
- Interventions
- H5N1 vaccine plus AS03 adjuvant, H5N1 vaccine without adjuvant
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 21 Years to 45 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Decatur, Georgia
Source: ClinicalTrials.gov public record
Updated Feb 11, 2019 · Synced May 22, 2026, 1:18 AM EDT